NCHADS laboratory provides HIV viral load (quantitative),
quantitative Early Infant HIV Diagnostic (EID), CD4 count, and Hepatitis C viral load testing services. Laboratory services played a key role in moving towards to reach Cambodia HIV/AIDS
epidemic controlby 2025, andreceiving globalrecognitionforbeingone of only seven countries in the
world to have achieved the interim "90-90-90" treatm
ent in July 2017. The National Center for
HIV/AIDS Dermatology and STD (NCHADS) laboratory provides HIV viral load (quantitative),
quantitative Early Infant HIV Diagnostic (EID), CD4 count, and Hepatitis C viral load testing services. The NCHADS Lab and the HIV Testing Services of NCHADS have jointly conducted HIV rapid
testing, and internal quality control trainings to all staff at the 69 Voluntary Counseling and Testing
(VCT) sites. In partnership with the National Institute of Public Health Laboratory, NCHADS also
provides HIV External Quality Assurance Scheme (EQAS) to allVCT sites and follows up with corrective
actions to underperforming sites. NCHADS leads in managing and coordinating the genotyping service with
Cambodia Institute Pasteur and Macrogen laboratory in Korea forpatients with repeated virologicalfailure
toidentify mutations fordrug resistance. The Strategic Plan for HIV and STI Prevention and Control in the Health Sector 2021-2025,
NCHADS lab plans to obtain ISO 15189 by 2024, and Siem Reap Lab plans to obtain Star-4 (LQMS
Check list) by 2022. In the PEPFAR Regional Operation Plan 2020 (by September 2021), more than 80%
of non-conformities of baseline assessment per ISO 15189 checklist findings are addressed. To meet
these purposes, NCHADS urgently requires one qualified candidate for a position “NCHADS
Laboratory International Standard Organization (ISO) Lead Officer”, who will provide technical and day-today operationalworkswith existing laboratory team members.
